Barclays PLC lifted its holdings in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 66.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,633 shares of the industrial products company's stock after purchasing an additional 17,017 shares during the quarter. Barclays PLC owned 0.17% of Proto Labs worth $1,252,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of the business. Canada Pension Plan Investment Board bought a new stake in Proto Labs during the 2nd quarter worth approximately $37,000. KBC Group NV boosted its holdings in shares of Proto Labs by 69.3% in the third quarter. KBC Group NV now owns 1,541 shares of the industrial products company's stock valued at $45,000 after buying an additional 631 shares during the period. Point72 Asia Singapore Pte. Ltd. increased its position in shares of Proto Labs by 40.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,108 shares of the industrial products company's stock worth $121,000 after acquiring an additional 1,186 shares in the last quarter. Meeder Asset Management Inc. raised its holdings in shares of Proto Labs by 72.3% during the third quarter. Meeder Asset Management Inc. now owns 4,465 shares of the industrial products company's stock worth $131,000 after acquiring an additional 1,873 shares during the period. Finally, Paloma Partners Management Co bought a new stake in Proto Labs in the 3rd quarter valued at $201,000. Institutional investors own 84.54% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the company. Needham & Company LLC reiterated a "hold" rating on shares of Proto Labs in a report on Friday, November 1st. Cantor Fitzgerald reiterated an "overweight" rating and set a $40.00 price objective on shares of Proto Labs in a report on Monday, November 4th. Finally, Craig Hallum lifted their target price on Proto Labs from $30.00 to $36.00 and gave the company a "hold" rating in a research report on Monday, November 4th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $40.33.
View Our Latest Research Report on Proto Labs
Proto Labs Price Performance
PRLB stock traded up $0.41 during midday trading on Tuesday, hitting $37.01. The company's stock had a trading volume of 129,166 shares, compared to its average volume of 147,933. The company's fifty day moving average price is $40.14 and its 200 day moving average price is $33.59. Proto Labs, Inc. has a twelve month low of $25.75 and a twelve month high of $45.15. The stock has a market capitalization of $907.12 million, a P/E ratio of 39.37 and a beta of 1.45.
Proto Labs (NYSE:PRLB - Get Free Report) last released its earnings results on Friday, November 1st. The industrial products company reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.32 by $0.15. Proto Labs had a return on equity of 3.49% and a net margin of 4.76%. The business had revenue of $125.60 million for the quarter, compared to the consensus estimate of $121.38 million. During the same quarter in the previous year, the business earned $0.31 earnings per share. Proto Labs's quarterly revenue was down 3.9% on a year-over-year basis. Equities analysts expect that Proto Labs, Inc. will post 0.84 EPS for the current fiscal year.
Proto Labs Profile
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Featured Stories
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.